ゲノミクスの世界市場レポート 2025年

ゲノミクス市場規模は、今後数年間で飛躍的な成長が見込まれます。2029年にはCAGR20.3％で1,127億8,000万米ドルに成長します。予測期間における成長の要因は、認知度の向上と教育、医薬品開発と治療、診断アプリケーション、規制と倫理的枠組みです。予測期間における主な動向としては、技術的進歩、農業におけるゲノムシーケンス、共同研究およびパートナーシップ、ゲノムデータ解析などが挙げられます。

ゲノミクス調査への政府投資の増加は、シングルセルゲノミクス市場拡大のカタリストとなっています。政府資金は、ヒトゲノムの複雑性を解明し、ヒトの健康と病気のゲノム基盤を理解し、患者ケアにおけるゲノミクスの安全で有益な利用を保証するために捧げられています。例えば、2022年12月、英国の政府サービス・情報プロバイダーであるGOV.UKは、英国政府がゲノムヘルスケアの強化のために2022年に1億7,500万英ポンド（2億2,983万米ドル）を割り当てたことを報告しました。この資金は、がんや希少な遺伝性疾患など、さまざまな疾患の診断と治療の改善を目的とした革新的な技術に重点が置かれています。これらのイニシアチブは、ゲノムシークエンシングのインフラを強化することを目的としており、3つの異なるフェーズにまたがって分配されます。

遺伝性疾患の増加が予想されることから、ゲノミクス市場の成長の原動力となることが期待されています。遺伝性疾患は、個人のDNAの不規則性に起因し、様々な身体的・精神的異常、疾患、特定の健康状態への素因が現れ、一般的に両親から受け継がれます。ゲノミクスは、個人の遺伝子データを調べることで、遺伝子疾患の正確な診断、個別化治療、リスク評価を可能にする上で極めて重要な役割を果たしています。例えば、2022年10月、イングランドの実施計画によると、Test Directoryには、希少疾患の臨床適応357項目が含まれ、約3,200の希少疾患と遺伝性疾患、およびがんの臨床適応203項目をカバーしています。このディレクトリーは、NHSのゲノム医療サービス（GMS）が、一般的な疾患や希少な遺伝性疾患、薬理ゲノミクス、がんを対象に、イングランドで年間68万件以上のゲノム検査を実施するのをサポートしています。その結果、遺伝性疾患の有病率の上昇がゲノミクス市場の成長を促進しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のゲノミクス PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のゲノミクス市場：成長率分析
• 世界のゲノミクス市場の実績：規模と成長、2019年～2024年
• 世界のゲノミクス市場の予測：規模と成長、2024年～2029年、2034年
• 世界のゲノミクス総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のゲノミクス市場：製品タイプ別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 機器（システム、サービス契約、ソフトウェアを含む）
• 試薬（試薬および消耗品を含む）
• 世界のゲノミクス市場：プロセス別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 細胞分離
• サンプル調製
• ゲノム解析
• 世界のゲノミクス市場：エンドユーザー別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 学術機関
• バイオ医薬品企業
• 臨床研究機関
• 世界のゲノミクス市場、機器のサブセグメンテーション、タイプ別、実績と予測、2019年～2024年、2024年～2029年、2034年
• システム
• サービス契約
• ソフトウェア
• 世界のゲノミクス市場、試薬のタイプ別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• キット
• 消耗品

第7章 地域別・国別分析

• 世界のゲノミクス市場：地域別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 世界のゲノミクス市場：国別、実績と予測、2019年～2024年、2024年～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ゲノミクス市場：競合情勢
• ゲノミクス市場：企業プロファイル
  • X Genomics Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Qiagen NV Overview, Products and Services, Strategy and Financial Analysis
  • Standard BioTools Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson and Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Affymetrix Inc.
• Angle plc
• Denovo Sciences Inc.
• Diagnologix LLC
• DNA Electronics Ltd.
• Epic Sciences
• Kellbenx Inc.
• Resolution Bioscience Inc.
• Wafergen Bio-systems Inc.
• Yikon Genomics Co. Ltd.
• Thermo Fisher Scientific Inc.
• Beckman Coulter Inc.
• Becton, Dickinson and Company
• Bio-Rad Laboratories Inc.
• Carl Zeiss Microscopy GmbH

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ゲノミクス市場2029年：新たな機会を提供する国
• ゲノミクス市場2029年：新たな機会を提供するセグメント
• ゲノミクス市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Genomics is the study of an organism's entire set of genes (genome), focusing on their structure, function, evolution, and mapping. It involves analyzing the sequencing and interactions of DNA, RNA, and proteins to understand how genes regulate biological processes and influence traits and diseases. Genomics is pivotal in fields such as medicine, agriculture, and biotechnology, driving advancements in personalized medicine, enhancing crop yields, and enabling the development of targeted therapies for genetic disorders.

The primary product types within genomics include instruments (comprising systems, service contracts, and software) and reagents (consisting of reagents and consumables). Reagents are substances or compounds added to a system to initiate a chemical reaction or to assess whether a reaction has occurred. Different processes within genomics encompass cell isolation, sample preparation, and genomic analysis, and these processes are employed by academic institutions, biopharmaceutical companies, and clinical research institutes.

The genomics market research report is one of a series of new reports from The Business Research Company that provides genomics market statistics, including genomics industry global market size, regional shares, competitors with a genomics market share, detailed genomics market segments, market trends and opportunities, and any further data you may need to thrive in the genomics industry. This genomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The genomics market size has grown rapidly in recent years. It will grow from $45.47 billion in 2024 to $53.92 billion in 2025 at a compound annual growth rate (CAGR) of 18.6%. The growth in the historic period can be attributed to reduction in sequencing costs, research and discovery, healthcare applications, personalized medicine.

The genomics market size is expected to see exponential growth in the next few years. It will grow to $112.78 billion in 2029 at a compound annual growth rate (CAGR) of 20.3%. The growth in the forecast period can be attributed to growing awareness and education, drug development and therapeutics, diagnostic applications, regulatory and ethical frameworks. Major trends in the forecast period include technological advancements, genomic sequencing in agriculture, collaboration and partnerships, genomic data analytics.

Increased government investment in genomics research has been a catalyst for the expansion of the single-cell genomics market. Government funds are dedicated to unraveling the complexities of the human genome, understanding the genomic foundations of human health and ailments, and ensuring the safe and beneficial utilization of genomics in patient care. For example, in December 2022, GOV.UK, a UK-based government services and information provider, reported that the UK government allocated £175 million ($229.83 million) in 2022 to enhance genomic healthcare. This funding focuses on innovative technologies aimed at improving the diagnosis and treatment of various diseases, including cancer and rare genetic disorders. These initiatives aim to fortify genomic sequencing infrastructure, disbursed across three distinct phases.

The anticipated rise in genetic disorder occurrences is expected to act as a driving force behind the growth of the genomics market. Genetic disorders, stemming from irregularities in an individual's DNA, manifest in various physical or mental abnormalities, diseases, or predisposition to certain health conditions, commonly inherited from parents. Genomics plays a pivotal role in enabling precise diagnosis, personalized treatments, and risk evaluation for genetic disorders by examining an individual's genetic data. For instance, in October 2022, according to the Implementation Plan for England, the Test Directory includes 357 clinical indications for rare diseases, covering approximately 3,200 rare and inherited diseases, as well as 203 clinical indications for cancer. This directory supports the NHS Genomic Medicine Service (GMS) in performing over 680,000 genomic tests annually in England for common and rare inherited diseases, pharmacogenomics, and cancer. Consequently, the rising prevalence of genetic disorders is driving growth in the genomics market.

Major companies in the genomics market are increasingly focused on technological advancements, such as long read technology, to improve genome sequencing accuracy, enable the analysis of larger and more complex genetic regions, and offer deeper insights into genetic variations that were previously challenging to detect. Long read technology involves sequencing longer DNA or RNA segments, allowing for more precise and comprehensive genetic analysis, and facilitating the detection of complex variations and disease-related markers. For example, in March 2023, Illumina Inc., a US-based biotechnology company, launched Illumina's Complete Long Read Prep. This solution offers an efficient, low-input approach for whole-genome sequencing, delivering both long- and short-read data on the same device with simplified workflows and requiring fewer materials compared to other technologies.

Prominent players within the genomics sector are actively engaged in the development of groundbreaking personalized medicine solutions. Personalized medicine is a paradigm shift that enables healthcare practitioners to tailor medical interventions precisely to individual patient needs. This approach not only ensures superior care outcomes but also heralds the potential to supplant conventional pharmaceuticals and surgical procedures through the emerging field of gene therapy. For example, in May 2022, Illumina, a leading US-based biotechnology company, entered into a strategic partnership with Janssen, a pharmaceutical company based in Belgium. This collaboration aims to expedite the advancement of precision medicines, harnessing Illumina's extensive resource portfolio, encompassing data analytics tools, early discovery research, companion diagnostics, and commercialization solutions. The alliance also seeks to streamline collaboration with pharmaceutical partners in various aspects, from novel drug target discovery to early screening, therapy selection, and monitoring.

In July 2024, Petrosys Pty Ltd, an Australia-based software company, acquired Talus Technologies Inc. for an undisclosed amount. Through this acquisition, Petrosys aims to enhance its portfolio of advanced software solutions for the energy and resource industries, with a particular focus on improving data visualization. Talus Technologies Inc., a Canada-based company, specializes in the discovery and development of therapeutics targeting transcription factors (TFs).

Major companies operating in the genomics market include 10X Genomics Inc., Qiagen NV, Standard BioTools Inc., Johnson and Johnson, Illumina Inc., Affymetrix Inc., Angle PLC, Denovo Sciences Inc., Diagnologix LLC, DNA Electronics Ltd., Epic Sciences, Kellbenx Inc., Resolution Bioscience Inc., Wafergen Bio-systems Inc., Yikon Genomics Co. Ltd., Thermo Fisher Scientific Inc., Beckman Coulter Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Carl Zeiss Microscopy GmbH, Cell Microsystems Inc., CellSorter, CYTENA GmbH, Dolomite Bio Limited, Agilent Technologies Inc., Fluxion Biosciences Inc., BGI Group, F. Hoffmann-La Roche AG, Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Eurofins Scientific SE, Danaher Corporation, PerkinElmer Inc.

North America was the largest region in the genomics market in 2024. Western Europe was the second largest region in the genomics market. The regions covered in the genomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the genomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The genomics market consists of sales of genomics such as structural genomes, functional genomes, mutation genomics and comparative genomics that are used for drug discovery and development. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Genomics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on genomics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for genomics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The genomics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Instrument (Including Systems, Service Contract And Software); Reagents (Including Reagents And Consumables)
• 2) By Process: Cell Isolation; Sample Preparation; Genomic Analysis
• 3) By End User: Academic Institutes; Biopharmaceutical Companies; Clinical Research Institutes
• Subsegments:
• 1) By Instrument: Systems; Service Contracts; Software
• 2) By Reagents: Kits; Consumables
• Companies Mentioned: 10X Genomics Inc.; Qiagen NV; Standard BioTools Inc.; Johnson and Johnson; Illumina Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Genomics Market Characteristics

3. Genomics Market Trends And Strategies

4. Genomics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Genomics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Genomics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Genomics Market Growth Rate Analysis
• 5.4. Global Genomics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Genomics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Genomics Total Addressable Market (TAM)

6. Genomics Market Segmentation

• 6.1. Global Genomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Instrument (Including Systems, Service Contract And Software)
• Reagents (Including Reagents And Consumables)
• 6.2. Global Genomics Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cell Isolation
• Sample Preparation
• Genomic Analysis
• 6.3. Global Genomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Academic Institutes
• Biopharmaceutical Companies
• Clinical Research Institutes
• 6.4. Global Genomics Market, Sub-Segmentation Of Instrument, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Systems
• Service Contracts
• Software
• 6.5. Global Genomics Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Kits
• Consumables

7. Genomics Market Regional And Country Analysis

• 7.1. Global Genomics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Genomics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Genomics Market

• 8.1. Asia-Pacific Genomics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Genomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Genomics Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Genomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Genomics Market

• 9.1. China Genomics Market Overview
• 9.2. China Genomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Genomics Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Genomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Genomics Market

• 10.1. India Genomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Genomics Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Genomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Genomics Market

• 11.1. Japan Genomics Market Overview
• 11.2. Japan Genomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Genomics Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Genomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Genomics Market

• 12.1. Australia Genomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Genomics Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Genomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Genomics Market

• 13.1. Indonesia Genomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Genomics Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Genomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Genomics Market

• 14.1. South Korea Genomics Market Overview
• 14.2. South Korea Genomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Genomics Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Genomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Genomics Market

• 15.1. Western Europe Genomics Market Overview
• 15.2. Western Europe Genomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Genomics Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Genomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Genomics Market

• 16.1. UK Genomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Genomics Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Genomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Genomics Market

• 17.1. Germany Genomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Genomics Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Genomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Genomics Market

• 18.1. France Genomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Genomics Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Genomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Genomics Market

• 19.1. Italy Genomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Genomics Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Genomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Genomics Market

• 20.1. Spain Genomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Genomics Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Genomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Genomics Market

• 21.1. Eastern Europe Genomics Market Overview
• 21.2. Eastern Europe Genomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Genomics Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Genomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Genomics Market

• 22.1. Russia Genomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Genomics Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Genomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Genomics Market

• 23.1. North America Genomics Market Overview
• 23.2. North America Genomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Genomics Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Genomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Genomics Market

• 24.1. USA Genomics Market Overview
• 24.2. USA Genomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Genomics Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Genomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Genomics Market

• 25.1. Canada Genomics Market Overview
• 25.2. Canada Genomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Genomics Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Genomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Genomics Market

• 26.1. South America Genomics Market Overview
• 26.2. South America Genomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Genomics Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Genomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Genomics Market

• 27.1. Brazil Genomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Genomics Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Genomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Genomics Market

• 28.1. Middle East Genomics Market Overview
• 28.2. Middle East Genomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Genomics Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Genomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Genomics Market

• 29.1. Africa Genomics Market Overview
• 29.2. Africa Genomics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Genomics Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Genomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Genomics Market Competitive Landscape And Company Profiles

• 30.1. Genomics Market Competitive Landscape
• 30.2. Genomics Market Company Profiles
  • 30.2.1.10X Genomics Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Qiagen NV Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Standard BioTools Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Johnson and Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Genomics Market Other Major And Innovative Companies

• 31.1. Affymetrix Inc.
• 31.2. Angle plc
• 31.3. Denovo Sciences Inc.
• 31.4. Diagnologix LLC
• 31.5. DNA Electronics Ltd.
• 31.6. Epic Sciences
• 31.7. Kellbenx Inc.
• 31.8. Resolution Bioscience Inc.
• 31.9. Wafergen Bio-systems Inc.
• 31.10. Yikon Genomics Co. Ltd.
• 31.11. Thermo Fisher Scientific Inc.
• 31.12. Beckman Coulter Inc.
• 31.13. Becton, Dickinson and Company
• 31.14. Bio-Rad Laboratories Inc.
• 31.15. Carl Zeiss Microscopy GmbH

32. Global Genomics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Genomics Market

34. Recent Developments In The Genomics Market

35. Genomics Market High Potential Countries, Segments and Strategies

• 35.1 Genomics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Genomics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Genomics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer